| Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with … S Mazloomzadeh, S Khaleghparast, B Ghadrdoost, M Mousavizadeh, ... Jama 325 (16), 1620-1630, 2021 | 678 | 2021 |
| Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review AH Talasaz, P Sadeghipour, H Kakavand, M Aghakouchakzadeh, ... Journal of the American College of Cardiology 77 (15), 1903-1921, 2021 | 187 | 2021 |
| Antibiotics for treating human brucellosis R Yousefi‐Nooraie, S Mortaz‐Hejri, M Mehrani, P Sadeghipour Cochrane Database of Systematic Reviews, 2012 | 179 | 2012 |
| International prospective registry of acute coronary syndromes in patients with COVID-19 TA Kite, PF Ludman, CP Gale, J Wu, A Caixeta, J Mansourati, M Sabate, ... Journal of the American College of Cardiology 77 (20), 2466-2476, 2021 | 110 | 2021 |
| Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the … B Bikdeli, AH Talasaz, F Rashidi, B Sharif-Kashani, M Farrokhpour, ... Thrombosis research 196, 382-394, 2020 | 87 | 2020 |
| Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19 admitted to the intensive care unit: 90-day results from the INSPIRATION … B Bikdeli, AH Talasaz, F Rashidi, H Bakhshandeh, F Rafiee, P Rezaeifar, ... Thrombosis and haemostasis 122 (01), 131-141, 2022 | 79 | 2022 |
| Cardiovascular complications of COVID-19: pharmacotherapy perspective AH Talasaz, H Kakavand, B Van Tassell, M Aghakouchakzadeh, ... Cardiovascular drugs and therapy 35, 249-259, 2021 | 57 | 2021 |
| Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review AH Talasaz, P Sadeghipour, M Aghakouchakzadeh, I Dreyfus, ... Journal of the American College of Cardiology 78 (16), 1635-1654, 2021 | 49 | 2021 |
| Catheter-directed thrombolysis vs anticoagulation in patients with acute intermediate-high–risk pulmonary embolism: the CANARY randomized clinical trial P Sadeghipour, Y Jenab, J Moosavi, K Hosseini, B Mohebbi, ... JAMA cardiology 7 (12), 1189-1197, 2022 | 48 | 2022 |
| Coronary stent fracture: a recently appreciated phenomenon with clinical relevance M Chinikar, P Sadeghipour Current cardiology reviews 10 (4), 349-354, 2014 | 33 | 2014 |
| Comparing acute and chronic human cutaneous leishmaniasis caused by Leishmania major and Leishmania tropica focusing on arginase activity H Mortazavi, P Sadeghipour, Y Taslimi, S Habibzadeh, F Zali, ... Journal of the European Academy of Dermatology and Venereology 30 (12), 2118 …, 2016 | 30 | 2016 |
| Management of ST‐segment‐elevation myocardial infarction during the coronavirus disease 2019 (COVID‐19) outbreak: Iranian “247” National Committee's position paper on primary … P Sadeghipour, AH Talasaz, V Eslami, B Geraiely, M Vojdanparast, ... Catheterization and Cardiovascular Interventions 97 (3), E346-E351, 2021 | 26 | 2021 |
| Validity and reliability of a virtual education satisfaction questionnaire from the perspective of cardiology residents during the COVID-19 pandemic B Ghadrdoost, P Sadeghipour, A Amin, H Bakhshandeh, F Noohi, ... Journal of Education and Health Promotion 10, 2021 | 26 | 2021 |
| COVID-19-associated pulmonary embolism: review of the pathophysiology, epidemiology, prevention, diagnosis, and treatment L Ortega-Paz, AH Talasaz, P Sadeghipour, TS Potpara, HD Aronow, ... Seminars in thrombosis and hemostasis, 2022 | 24 | 2022 |
| Efficacy and safety considerations with dose-reduced direct oral anticoagulants: a review B Bikdeli, FZ Tajrishi, P Sadeghipour, AH Talasaz, J Fanikos, G Lippi, ... JAMA cardiology 7 (7), 747-759, 2022 | 23 | 2022 |
| Cytotoxic effect of drugs eluted from polymethylmethacrylate on stromal giant-cell tumour cells: an in vitro study DG Savadkoohi, P Sadeghipour, H Attarian, S Sardari, A Eslamifar, ... The Journal of Bone & Joint Surgery British Volume 90 (7), 973-979, 2008 | 23 | 2008 |
| Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE … A Marashizadeh, HR Sanati, P Sadeghipour, MM Peighambari, J Moosavi, ... International Urology and Nephrology 51, 1815-1822, 2019 | 21 | 2019 |
| Warning signals of elevated prediabetes prevalence in the modern Iranian urban population S Barati, P Sadeghipour, Z Ghaemmaghami, B Mohebbi, M Baay, ... Primary care diabetes 15 (3), 472-479, 2021 | 18 | 2021 |
| COVID-19 sends STEMI to quarantine!? S Abdi, M Salarifar, SH Mortazavi, P Sadeghipour, B Geraiely Clinical Research in Cardiology 109, 1567-1568, 2020 | 15 | 2020 |
| Percutaneous transluminal mitral commissurotomy in pregnant women with severe mitral stenosis A Firouzi, N Samiei, S Ahmadi, N Naderi, P Sadeghipour, HR Sanati, ... The Journal of Tehran University Heart Center 14 (1), 12, 2019 | 15 | 2019 |
